Ball to Announce Third Quarter Earnings on November 4, 2025
WESTMINSTER, Colo., Oct. 7, 2025 /PRNewswire/ — Ball Corporation (NYSE: BALL) will announce its third quarter 2025 earnings on Tuesday, November 4, 2025... Read more.
EchoStar Corporation Announces Conversion Period for 3.875% Convertible Senior Secured Notes due 2030
ENGLEWOOD, Colo., Oct. 7, 2025 /PRNewswire/ — EchoStar Corporation (NASDAQ: SATS) (the “Company”) has notified holders of its 3.875% Convertible... Read more.
eHealth Announces Extension of Blue Torch Term Loan
eHealth Reaffirms its Commitment to Enhance Capital Structure Beyond this Deal AUSTIN, Texas, Oct. 7, 2025 /PRNewswire/ — eHealth, Inc. (Nasdaq: EHTH), a leading... Read more.
Tommie Copper Acquires Freeze Sleeve
MOUNT KISCO, N.Y., Oct. 7, 2025 /PRNewswire/ — Tommie Copper, the pioneer of Wearable Wellness, announced that it has acquired Freeze Sleeve, the innovators... Read more.
PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR
Standalone P&HS anticipated to benefit from Platinum’s carve-out experience, sector expertise and commitment to growth Owens & Minor to retain a 5%... Read more.
Flotek Announces Third Quarter 2025 Earnings Release and Conference Call Schedule
HOUSTON, Oct. 7, 2025 /PRNewswire/ — Flotek Industries, Inc. (“Flotek” or the “Company”) (NYSE: FTK) today announced the Company’s... Read more.
Powerfleet Appoints Jeff Lautenbach as Chief Revenue Officer to Amplify Accelerated SaaS Revenue Growth
WOODCLIFF LAKE, N.J., Oct. 7, 2025 /PRNewswire/ — Powerfleet, Inc. (Nasdaq: AIOT), a global leader in the artificial intelligence of things (AIoT) SaaS... Read more.
ICF Updates Sightline®, Its Highly Adopted Utility Program Platform
New AI Capabilities Enhance Program Design & Delivery RESTON, Va., Oct. 7, 2025 /PRNewswire/ — ICF (NASDAQ:ICFI), a leading global solutions and... Read more.
TruDiagnostic Awarded NIH SBIR Grant to Advance Breakthrough Epigenetic Diagnostic Technology
LEXINGTON, Ky., Oct. 7, 2025 /PRNewswire/ — TruDiagnostic, a leader in epigenetic testing and health analytics, announced today it has received a competitive... Read more.
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results
Conference Call and Webcast Scheduled for Tuesday, October 28 SAN DIEGO, Oct. 7, 2025 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced... Read more.